Comparison of the Safety of Intracameral Levofloxacin to intracameral Cefuroxime for the prevention of endophthalmitis in cataract surgery (SILC): a single centre prospective double-blind randomised controlled trial.

Trial Profile

Comparison of the Safety of Intracameral Levofloxacin to intracameral Cefuroxime for the prevention of endophthalmitis in cataract surgery (SILC): a single centre prospective double-blind randomised controlled trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Oct 2011

At a glance

  • Drugs Levofloxacin (Primary) ; Cefuroxime
  • Indications Bacterial infections; Endophthalmitis
  • Focus Therapeutic Use
  • Acronyms SILC
  • Most Recent Events

    • 02 Oct 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
    • 15 Jun 2010 Planned end date changed from 31 Aug 2010 to 1 Oct 2011 as reported by ISRCTN: Current Controlled Trials record.
    • 15 Jun 2010 Planned number of patients changed from 36 to 14 as reported by ISRCTN: Current Controlled Trials record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top